Ignite Proteomics introduces the only commercially available and clinically validated assay that can measure both the expression and activated protein drug target levels in breast tumors performed in a CAP/CLIA approved setting
| Website | http://www.igniteproteomics.com |
| Employees | 14 (7 on RocketReach) |
| Founded | 2024 |
| Industry | Medical and Diagnostic Laboratories |
| Keywords | Proteomics, Drug Target Identification, Clinical Proteomics, Protein Analysis, Clinical Diagnostics, Biomarker Discovery, Cancer Diagnostics, Assay Development, Molecular Diagnostics, Protein Quantification, Breast Cancer Research, Tumor Analysis, Precision Medicine, Biotechnology, Life Sciences |
| Competitors | Roche, Thermo Fisher Scientific, Abbott, Agilent Technologies, Danaher Corporation, PerkinElmer, Inc., Waters Corporation, Bruker, SCIEX, Molecular Devices +44 more (view full list) |
Looking for a particular Ignite Proteomics employee's phone or email?
Justin Davis is the Vice President of Research and Development of Ignite Proteomics.
7 people are employed at Ignite Proteomics.